therabreath anticavity

Generic: sodium fluoride

Labeler: church & dwight co., inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name therabreath anticavity
Generic Name sodium fluoride
Labeler church & dwight co., inc.
Dosage Form RINSE
Routes
ORAL
Active Ingredients

sodium fluoride .005 mg/10mL

Manufacturer
Church & Dwight Co., Inc.

Identifiers & Regulatory

Product NDC 10237-260
Product ID 10237-260_3e62d7f4-bc39-39ec-e063-6394a90a1c90
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M021
Listing Expiration 2026-12-31
Marketing Start 2023-02-13

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10237260
Hyphenated Format 10237-260

Supplemental Identifiers

UPC
0697029192030
UNII
8ZYQ1474W7

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name therabreath anticavity (source: ndc)
Generic Name sodium fluoride (source: ndc)
Application Number M021 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .005 mg/10mL
source: ndc
Packaging
  • 1000 mL in 1 BOTTLE, PLASTIC (10237-260-01)
  • 88.7 mL in 1 BOTTLE, PLASTIC (10237-260-03)
  • 473 mL in 1 BOTTLE, PLASTIC (10237-260-16)
  • 2 BOTTLE in 1 PACKAGE (10237-260-26) / 473 mL in 1 BOTTLE
source: ndc

Packages (4)

Ingredients (1)

sodium fluoride (.005 mg/10mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3e62d7f4-bc39-39ec-e063-6394a90a1c90", "openfda": {"upc": ["0697029192030"], "unii": ["8ZYQ1474W7"], "spl_set_id": ["feab3d45-ff95-4b32-8258-7d932a7380c9"], "manufacturer_name": ["Church & Dwight Co., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 mL in 1 BOTTLE, PLASTIC (10237-260-01)", "package_ndc": "10237-260-01", "marketing_end_date": "20260913", "marketing_start_date": "20230213"}, {"sample": false, "description": "88.7 mL in 1 BOTTLE, PLASTIC (10237-260-03)", "package_ndc": "10237-260-03", "marketing_start_date": "20230213"}, {"sample": false, "description": "473 mL in 1 BOTTLE, PLASTIC (10237-260-16)", "package_ndc": "10237-260-16", "marketing_start_date": "20230213"}, {"sample": false, "description": "2 BOTTLE in 1 PACKAGE (10237-260-26)  / 473 mL in 1 BOTTLE", "package_ndc": "10237-260-26", "marketing_start_date": "20250528"}], "brand_name": "Therabreath Anticavity", "product_id": "10237-260_3e62d7f4-bc39-39ec-e063-6394a90a1c90", "dosage_form": "RINSE", "product_ndc": "10237-260", "generic_name": "SODIUM FLUORIDE", "labeler_name": "Church & Dwight Co., Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Therabreath Anticavity", "active_ingredients": [{"name": "SODIUM FLUORIDE", "strength": ".005 mg/10mL"}], "application_number": "M021", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230213", "listing_expiration_date": "20261231"}